Methylphenidate causes chronic eosinophilic pneumonia.
Autor: | Alghamdi D; Department of Pulmonology, King Abdulaziz Medical City, Riyadh, Saudi Arabia., Jahdali H; Department of Pulmonology, King Abdulaziz Medical City, Riyadh, Saudi Arabia., Alharbi A; Department of Pulmonology, King Abdulaziz Medical City, Riyadh, Saudi Arabia., Alshehri A; Department of Psychiatry, King Abdulaziz Medical City, Riyadh, Saudi Arabia., Alfirm B; Department of Psychiatry, King Abdulaziz Medical City, Riyadh, Saudi Arabia., Bamefleh H; Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia. |
---|---|
Jazyk: | angličtina |
Zdroj: | Annals of thoracic medicine [Ann Thorac Med] 2024 Jan-Mar; Vol. 19 (1), pp. 112-115. Date of Electronic Publication: 2024 Jan 25. |
DOI: | 10.4103/atm.atm_260_23 |
Abstrakt: | A man who is 38 years old and diagnosed with attention-deficit hyperactivity disorder was prescribed methylphenidate. Three weeks later, he began experiencing progressive shortness of breath and coughing. Imaging of his chest showed patchy bilateral ground-glass opacities, and bronchoscopy revealed a 15% eosinophil count in his bronchoalveolar lavage. A transbronchial biopsy confirmed a diagnosis of eosinophilic pneumonia. The patient's condition improved when he was given steroids and stopped taking methylphenidate. However, he developed the same symptoms again a few days after restarting the medication, along with a skin rash. This strongly suggests that methylphenidate was the cause of his eosinophilic pneumonia. Competing Interests: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. (Copyright: © 2024 Annals of Thoracic Medicine.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |